Shalby Ltd

Shalby Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Shalby Ltd

₹ 276 0.75%
23 Apr 3:31 p.m.
shalby.org BSE: 540797 NSE : SHALBY
About

Shalby Ltd is engaged in healthcare delivery space in India. It operates a chain of multi-specialty hospitals across India. The business of the company is to offer tertiary and quaternary healthcare services to patients in various areas of specialization such as orthopaedics, complex joint replacements, cardiology, neurology, oncology, renal transplantations, etc.[1]
The company is the global leader in knee replacement surgery and one of the top Indian hospitals in joint replacement surgery.

Key Points

Hospitals Portfolio
The co. operates 14 hospitals across India with a total bed capacity of 2,000+ beds. It also owns 60 outpatient clinics across 16 states in India and 5 OP clinics in African Countries. [1] [2] The co. has two upcoming facilities with a combined capacity of 321 beds will be located in Maharashtra. [3]

Website BSE NSE
  • Market Cap ₹ 2,979 Cr.
  • Current Price ₹ 276
  • High / Low ₹ 340 / 135
  • Stock P/E 36.6
  • Book Value ₹ 89.2
  • Dividend Yield 0.44 %
  • ROCE 10.6 %
  • ROE 7.37 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has been maintaining a healthy dividend payout of 21.5%
  • Debtor days have improved from 60.4 to 48.2 days.

Cons

  • Stock is trading at 3.07 times its book value
  • Company has a low return on equity of 6.43% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
132 145 192 182 162 163 202 202 202 199 235 238 216
101 114 154 152 134 139 162 165 169 173 192 185 174
Operating Profit 31 31 38 29 28 24 40 37 34 26 43 53 42
OPM % 23% 21% 20% 16% 17% 15% 20% 18% 17% 13% 18% 22% 20%
2 2 3 3 -2 4 4 5 4 9 5 5 5
Interest 1 1 1 2 2 2 2 2 3 3 3 3 4
Depreciation 9 9 9 11 11 11 12 12 12 13 12 12 12
Profit before tax 23 23 31 19 14 15 31 29 24 19 33 43 31
Tax % 26% 58% 34% 44% 6% 34% 34% 36% 35% 28% 37% 35% 38%
17 10 20 11 13 10 20 18 15 14 21 28 19
EPS in Rs 1.56 0.91 1.87 1.00 1.20 0.95 1.86 1.70 1.42 1.29 1.93 2.55 1.77
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
259 275 290 324 378 462 487 431 699 805 888
196 207 235 252 299 379 404 342 577 667 725
Operating Profit 63 68 56 71 79 83 83 89 122 138 164
OPM % 24% 25% 19% 22% 21% 18% 17% 21% 17% 17% 18%
2 2 2 7 10 9 17 8 8 22 24
Interest 2 5 10 11 12 9 7 5 8 11 12
Depreciation 11 21 11 17 23 33 36 37 43 48 49
Profit before tax 52 43 36 50 54 50 57 55 79 102 126
Tax % 28% 43% -1% 43% 27% 37% 51% 23% 32% 34%
38 25 36 29 39 32 28 42 54 68 81
EPS in Rs 11.17 7.36 4.30 3.40 3.65 2.93 2.55 3.93 5.01 6.27 7.54
Dividend Payout % 0% 0% 0% 0% 0% 17% 20% 25% 20% 19%
Compounded Sales Growth
10 Years: %
5 Years: 16%
3 Years: 18%
TTM: 16%
Compounded Profit Growth
10 Years: %
5 Years: 11%
3 Years: 35%
TTM: 27%
Stock Price CAGR
10 Years: %
5 Years: 16%
3 Years: 33%
1 Year: 89%
Return on Equity
10 Years: %
5 Years: 5%
3 Years: 6%
Last Year: 7%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 35 35 87 87 108 108 108 108 108 107 107
Reserves 106 133 117 164 643 672 691 727 768 820 857
Preference Capital 0 0 1 0 0 0 0 0 0 0
37 98 224 328 114 71 62 44 155 142 161
39 85 76 99 96 89 105 118 162 212 191
Total Liabilities 217 351 504 679 961 939 967 997 1,194 1,281 1,316
130 175 319 323 650 692 672 660 675 685 686
CWIP 5 91 82 221 47 3 6 8 6 11 6
Investments 0 0 0 0 0 11 28 16 25 146 134
81 85 102 134 264 233 260 314 488 440 490
Total Assets 217 351 504 679 961 939 967 997 1,194 1,281 1,316

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
60 14 43 55 79 19 68
-153 -236 1 -31 -51 -60 -61
96 222 -51 -22 -30 90 -50
Net Cash Flow 3 0 -6 3 -2 49 -43

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 21 29 40 38 49 64 71 80 53 48
Inventory Days 77 113 119 105 242 1,152
Days Payable 395 462 522 415 606 546
Cash Conversion Cycle 21 29 40 -280 -299 -339 -239 -283 53 654
Working Capital Days 35 -46 -26 -34 -3 57 70 84 109 108
ROCE % 22% 13% 12% 9% 7% 7% 7% 10% 11%

Shareholding Pattern

Numbers in percentages

2 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
74.07% 74.02% 74.02% 74.02% 74.04% 74.04% 74.12% 74.12% 74.12% 74.12% 74.12% 74.24%
3.68% 4.17% 3.83% 3.95% 3.92% 3.78% 3.97% 3.92% 4.00% 4.11% 4.62% 4.88%
0.00% 0.00% 0.00% 0.00% 0.00% 0.28% 0.06% 0.00% 0.00% 0.00% 0.00% 0.00%
21.32% 20.88% 21.22% 21.10% 21.12% 20.97% 20.97% 21.09% 21.00% 20.90% 20.42% 20.13%
0.93% 0.93% 0.93% 0.93% 0.93% 0.93% 0.87% 0.87% 0.87% 0.87% 0.83% 0.76%
No. of Shareholders 52,52453,85455,56255,23354,66654,53752,77552,18152,58050,22549,49549,858

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls